Advertisement

Topics

Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio

03:00 EDT 30 Oct 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Novartis International AG / Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of th...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...